Abstract
Polymeric magnetic nanoparticles due to their ability in overcoming drug retention in targeted organs have been noticed for localized drug delivery. Methotrexate (MTX) is one of the most frequently used chemotherapeutic agent and disease modifying anti-rheumatic drug with high hydrophilicity feature which leads to its rapid clearance even in local injections. The aim of this study is to prepare and evaluate MTX-loaded PLGA magnetic nanoparticles (MPNPs) to overcome these obstacles. MPNPs were prepared using double emulsion-solvent evaporation method and characterized. The particles size, morphology, magnetization saturation, drug and magnetite encapsulation efficiency, MTX release pattern from particles and cytotoxicity were evaluated. Using different drug to polymer ratio, PVA concentration and stirring speed, the minimum particle size of 390 nm was acquired. Approximately, 94.57% drug encapsulation efficiency resulted by further optimization. These particles have magnetization saturation of about 43emu/g with no remanence time and showed similar cell cytotoxicity in comparison with MTX solution. Considering the appropriate in vitro properties of selected MPNPs for magnetically guided drug targeting, it seems that promising results in reducing MTX side effects maybe expectable in further in vivo studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
